(Q43987754)

English

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

author name string

Wilson AM

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Orr LC

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Coutie WJ

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sims EJ

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Lipworth BJ

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

126-132

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Investigation into the increase in hay fever and eczema at age 16 observed between the 1958 and 1970 British birth cohorts

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

ABC of allergies. Summer hay fever

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Soluble markers of allergic inflammation

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Assessment of nasal airway patency: a comparison of four methods.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0022-0477.2001.01252.X

21 January 2018

Identifiers

10.1046/J.0022-0477.2001.01252.X

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43987754&oldid=2105339233"